Web Producer: Kerry Corum
Finally, what may be good news about hormone replacement therapy.
Recent results of a small study suggest, cutting the dose of estrogen may be the key to getting the bone building benefits, without the health risks.
A major trial with higher doses was stopped last summer, when the combination of estrogen and progesterone was linked to an increased risk of heart disease and breast cancer.
This three-year study, of less than 200 postmenopausal women, tested a quarter of the dose of estrogen women are usually prescribed.